Diversity & Inclusion
Biotechnology / Education / STEM / Universities

UMB, MedImmune enter $6M partnership for bioscience research

"MedImmune and UMB will both contribute funding and scientists to work on joint research projects."

Gaithersburg-based biotech firm MedImmune and the University of Maryland, Baltimore (UMB), have embarked on a five-year, $6 million partnership to push bioscience research in Maryland.
According to a press release:

MedImmune and UMB will both contribute funding and scientists to work on joint research projects, and will provide opportunities for scientific exchange and educational training between MedImmune and UMB scientists, students, and post docs.

MedImmune is contributing $5 million to the fund, with the remaining $1 million coming from UMB.

Companies: University of Maryland, Baltimore / MedImmune

Before you go...

Please consider supporting Technical.ly to keep our independent journalism strong. Unlike most business-focused media outlets, we don’t have a paywall. Instead, we count on your personal and organizational support.

Our services Preferred partners The journalism fund
Engagement

Join our growing Slack community

Join 5,000 tech professionals and entrepreneurs in our community Slack today!

Trending

How to encourage more healthcare entrepreneurship (and why that matters)

Find out what type of heat wave you’re really in for with NOAA’s HeatRisk dashboard

How AI can revolutionize education's quest for truth

Baltimore Money Moves: Howard County cyber company lands $150M Series D

Technically Media